Respiratory syncytial virus (RSV) (A2) fusion glycoprotein / RSV-f protein (his tag)

Ended Purchase Order Awarded

Contract number
HHSN272201701221P
Awardee
Awarding agency
Obligated
$12,257

Award facts

Opportunity
Contract value 100% obligated
$12,256.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6509 Drugs And Biologicals, Veterinary Use
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Burlington, NC, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This contract was awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to Cedarlane Laboratories USA, Inc. The contract is for the delivery of the respiratory syncytial virus (RSV) (A2) fusion glycoprotein/RSV-F protein (his tag). It is a firm fixed-price purchase order with a potential value of $12,256.75 and a completion date of October 27, 2017. The contract was not set aside for any specific business type.

Quick answers

Who was awarded contract HHSN272201701221P?

HHSN272201701221P was awarded to Cedarlane Laboratories Usa, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2017.

How much is contract HHSN272201701221P worth?

The government has obligated $12,257 on HHSN272201701221P.

Was contract HHSN272201701221P competed?

The extent of competition for HHSN272201701221P was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login